• news.cision.com/
  • Vigmed/
  • Vigmed announces a fully guaranteed rights issue of approximately SEK 57 million.
English

Vigmed announces a fully guaranteed rights issue of approximately SEK 57 million.

Report this content

For further information, please visit:

https://www.vigmed.com/investor/share-issue.aspx

For further information contact:

Chairman of the board, Lennart Holm +46 70 630 8562 or CEO, Henrik Olsen +46 76 349 7364

Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries and the associated risk of cross infections with blood-borne infectious diseases by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG) and has approximately 5 500 shareholders. Remium Nordic AB is the Company’s Certified Advisor. Additional information about the company can be found on Vigmed’s website: www.vigmed.com/investor

Tags:

Vigmed